Chimeric Therapeutics Ltd (ASX:CHM) Share Price and News - StockTrack

Market Cap (19-Sep) $3,502,596 (1,007th)	Close (30-Jun) $0.038 0 (0%)	Volume (30-Jun) 1,963,571	Shortsold (11-May) 1 (0.00%) (717th)
52w High $0.60	52w Low $0.064	P/E -	EPS -0.84

	Subject
	CHM CHM Ann: Initial Director's Interest Notice - JC
	1 (current) 2 3
	CHM CHM Ann: Notice under section 708A
	CHM CHM Ann: Preliminary Final Report
	CHM CHM Ann: Chimeric Appoints Jennifer Chow as CEO & MD
	CHM CHM Ann: Notification regarding unquoted securities - CHM
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Release of ordinary shares from escrow
	CHM CHM Ann: IND clearance received from US FDA for CHM 1101
	CHM CHM Ann: Change of Director's Interest Notice - GM
	CHM CHM Ann: Dr Yi Lin appointed to Cellular Immunotherapy SAB
	CHM CHM Ann: Chimeric Therapeutics CDH17 Investor Webinar
	CHM CHM Ann: Chimeric licenses novel solid tumor CAR T therapy from Penn
	CHM CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CHM CHM Ann: Initial Director's Interest Notice - GM
	CHM CHM Ann: Celgene Veteran Dr George Matcham Appointed to Board
	CHM CHM Ann: Dr Li Ren Joins as Vice President Technical Operations
	CHM CHM Ann: Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial
	CHM CHM Ann: Appendix 2A and 708A Notice
	CHM CHM Ann: Proposed issue of Securities - CHM
	CHM CHM Ann: CLTX CAR T Abstract Accepted for Presentation at ASCO
	CHM CHM Ann: Appendix 4C - quarterly
	CHM CHM Ann: Successful Completion of First Patient Cohort Phase 1 Trial
	CHM CHM Ann: Investor Presentation
	CHM CHM Ann: Successful Completion of Dosing in First Patient Cohort
	CHM CHM Ann: Chimeric to Present at NWR Virtual Investor Conference
	CHM CHM Ann: Change of Director's Interest Notice - CE
	CHM CHM Ann: Half Yearly Report and Accounts
	CHM CHM Ann: Dr Bourk former KITE PHARMA Senior Executive Joins Chimeric
	CHM CHM Ann: Initial Director's Interest Notice (Amended) - PH
	CHM CHM Ann: Change of Director's Interest Notice - LC
	CHM CHM Ann: Initial Director's Interest Notice - CE
	CHM CHM Ann: Former Juno Executive Cindy Elkins Joins Chimeric Board
	CHM CHM Ann: Dr Yvonne Chen Appointed to CHM Scientific Advisory Board
	CHM CHM Ann: Change of Director's Interest Notice - LC
	CHM CHM Ann: Becoming a substantial holder - PH
	CHM CHM Ann: Initial Director's Interest Notice - PH
	CHM CHM Ann: Initial Director's Interest Notice - LC
	CHM CHM Ann: Initial Director's Interest Notice - LR
	CHM CHM Ann: Chimeric Therapeutics Commences Trading on the ASX
	CHM CHM Ann: Pre-Quotation Disclosure
	CHM CHM Ann: Top 20 Holders
	CHM CHM Ann: Distribution Schedule
	CHM CHM Ann: Securities Trading Policy
	CHM CHM Ann: Omnibus Incentive Plan Rules
	CHM CHM Ann: Annual Report 30 June 2020
	CHM CHM Ann: Constitution
	CHM CHM Ann: Prospectus
	CHM CHM Ann: Appendix 1A and Information Form and Checklist
	CHM CHM Ann: ASX Market Release - Admission and Quotation

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	3,199,999	+0.00 (33.33%)
12-Sep	$0.00	1,621,588	0.00 (0.00%)
11-Sep	$0.00	4,147,698	0.00 (0.00%)
05-Sep	$0.00	33,560,043	+0.00 (50.00%)
04-Sep	$0.00	14,909,951	0.00 (33.33%)
03-Sep	$0.00	2,714,060	0.00 (0.00%)
29-Aug	$0.00	12,601,385	0.00 (0.00%)
28-Aug	$0.00	31,406,613	0.00 (0.00%)
22-Aug	$0.00	9,836	0.00 (0.00%)
21-Aug	$0.00	1,597,558	0.00 (0.00%)
15-Aug	$0.00	17,970,592	0.00 (14.29%)
14-Aug	$0.00	165,625	+0.00 (16.67%)
07-Aug	$0.00	4,812,305	0.00 (0.00%)
31-Jul	$0.00	3,775,000	0.00 (25.00%)
30-Jul	$0.00	312,291	+0.00 (33.33%)
4 up, 3 down, and 8 flat days

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

Chimeric Therapeutics Ltd Health Care

$0.038 0.001 (2.70%)

$0.038 0.001 (2.70%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices